When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies'. Together they form a unique fingerprint.

Medicine & Life Sciences